Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference8 articles.
1. Overcoming barriers to referral for chimeric antigen receptor T cell therapy in patients with relapsed/refractory diffuse large B cell lymphoma;Hoffmann;Transplant Cell Ther,2023
2. The ASTCT-NMDP ACCESS Initiative: a collaboration to address and sustain equal outcomes for all across the hematopoietic cell transplantation and cellular therapy ecosystem;Auletta;Transplant Cell Ther,2022
3. World Bank. GNI per capita, Atlas method (current US$)—India. https://data.worldbank.org/indicator/NY.GNP.PCAP.CD?end=2021&locations=IN&start=1962&view=chart. Accessed June 25, 2023.
4. American Society of Hematology. CAR T-cell therapies predicted to cost more than $1 million per patient.https://ashpublications.org/ashclinicalnews/news/3469/CAR-T-Cell-Therapies-Predicted-to-Cost-More-Than-1. Accessed June 25, 2023.
5. Cost of HSCT in a tertiary care public sector hospital in India;Goel;Indian J Hematol Blood Transfus,2022